Insider trading

Period: 120 months Stock: TVTX + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

352 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

352 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

352 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

352 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
352 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
352 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

352 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
2 Feb 2021
Rosenberg Noah L. Chief Medical Officer
Sold, plan not stated 2×
$55.75K 1,813 at 30.75
3.8%
2 Feb 2021
Heerma Peter Chief Commercial Officer
Sold, plan not stated
$17.31K 563 at 30.75
1.0%
6 Jan 2021
Dube Eric M Chief Executive Officer
Sold, plan not stated
$92.86K 3,438 at 27.01
3.8%
6 Jan 2021
REED ELIZABETH E SVP, GC & Corporate Secretary
Sold, plan not stated
$18.58K 688 at 27.01
2.8%
5 Jan 2021
Dube Eric M Chief Executive Officer
Sold, plan not stated
$91.62K 3,438 at 26.65
3.6%
5 Jan 2021
REED ELIZABETH E SVP, GC & Corporate Secretary
Sold, plan not stated
$18.34K 688 at 26.65
2.7%
15 Dec 2020
ASELAGE STEVE Director
Sold, plan not stated
$144.38K 5,549 at 26.02
2.7%
2 Dec 2020
ASELAGE STEVE Director
Sold, plan not stated
$184.85K 7,891 at 23.43
3.8%
25 Nov 2020
Clague Laura Chief Financial Officer
Sold, plan not stated
$85.20K 3,750 at 22.72
16.1%
24 Nov 2020
Clague Laura Chief Financial Officer
Sold, plan not stated
$89.48K 3,750 at 23.86
13.9%
16 Nov 2020
Clague Laura Chief Financial Officer
Sold, plan not stated
$179.81K 7,500 at 23.98
27.8%
16 Nov 2020
REED ELIZABETH E SVP, GC & Corporate Secretary
Sold, plan not stated
$59.95K 2,500 at 23.98
9.0%
16 Nov 2020
ROTE WILLIAM E. Senior Vice President, R&D
Sold, plan not stated
$59.90K 2,500 at 23.96
9.4%
13 Nov 2020
Clague Laura Chief Financial Officer
Sold, plan not stated
$177.07K 7,500 at 23.61
21.8%
13 Nov 2020
ROTE WILLIAM E. Senior Vice President, R&D
Sold, plan not stated
$59.06K 2,500 at 23.62
8.6%
13 Nov 2020
REED ELIZABETH E SVP, GC & Corporate Secretary
Sold, plan not stated
$59.05K 2,500 at 23.62
8.2%
6 Nov 2020
ASELAGE STEVE Director
Sold, plan not stated
$474.38K 20,625 at 23.00
8.8%
5 Nov 2020
ASELAGE STEVE Director
Sold, plan not stated
$53.15K 2,500 at 21.26
1.1%
5 Oct 2020
Heerma Peter Chief Commercial Officer
Sold, plan not stated
$42.34K 2,188 at 19.35
4.9%
2 Oct 2020
Heerma Peter Chief Commercial Officer
Sold, plan not stated
$41.35K 2,188 at 18.90
4.7%
23 Sep 2020
ROTE WILLIAM E. Senior Vice President, R&D
Sold, plan not stated
$27.72K 1,500 at 18.48
5.9%
23 Sep 2020
REED ELIZABETH E SVP, GC & Corporate Secretary
Sold, plan not stated
$27.72K 1,500 at 18.48
5.6%
23 Sep 2020
Clague Laura Chief Financial Officer
Sold, plan not stated
$27.72K 1,500 at 18.48
7.2%
23 Sep 2020
Rosenberg Noah L. Chief Medical Officer
Sold, plan not stated
$13.86K 750 at 18.48
2.6%
22 Sep 2020
ROTE WILLIAM E. Senior Vice President, R&D
Sold, plan not stated
$27.89K 1,500 at 18.59
5.5%
22 Sep 2020
REED ELIZABETH E SVP, GC & Corporate Secretary
Sold, plan not stated
$27.89K 1,500 at 18.59
5.3%
22 Sep 2020
Clague Laura Chief Financial Officer
Sold, plan not stated
$27.89K 1,500 at 18.59
6.7%
22 Sep 2020
Rosenberg Noah L. Chief Medical Officer
Sold, plan not stated
$13.94K 750 at 18.59
2.6%
21 Sep 2020
Dube Eric M Chief Executive Officer
Sold, plan not stated 2×
$208.32K 10,805 at 19.28
10.2%
5 Aug 2020
ASELAGE STEVE Director
Sold, plan not stated
$49.20K 2,500 at 19.68
1.0%
28 Jul 2020
Rosenberg Noah L. Chief Medical Officer
Sold, plan not stated
$17.83K 870 at 20.49
3.2%
25 Jun 2020
ASELAGE STEVE Director
Sold, plan not stated
$200.00K 10,000 at 20.00
4.0%
14 May 2020
ASELAGE STEVE Director
Sold, plan not stated
$46.21K 3,062 at 15.09
1.2%
13 May 2020
ASELAGE STEVE Director
Sold, plan not stated
$66.67K 4,063 at 16.41
1.6%
12 May 2020
Clague Laura Chief Financial Officer
Sold, plan not stated 2×
$30.40K 1,777 at 17.11
8.4%
12 May 2020
ROTE WILLIAM E. Senior Vice President, R&D
Sold, plan not stated 2×
$22.88K 1,339 at 17.09
5.4%
12 May 2020
REED ELIZABETH E SVP, GC & Corporate Secretary
Sold, plan not stated 2×
$17.96K 1,052 at 17.07
4.0%
12 May 2020
ASELAGE STEVE Director
Sold, plan not stated
$17.16K 1,000 at 17.16
0.4%
12 May 2020
Rosenberg Noah L. Chief Medical Officer
Sold, plan not stated
$8.95K 527 at 16.98
1.9%
11 May 2020
Clague Laura Chief Financial Officer
Sold, plan not stated
$18.69K 1,250 at 14.95
5.6%
11 May 2020
ROTE WILLIAM E. Senior Vice President, R&D
Sold, plan not stated
$12.15K 813 at 14.95
3.2%
11 May 2020
REED ELIZABETH E SVP, GC & Corporate Secretary
Sold, plan not stated
$7.85K 525 at 14.95
1.9%
5 May 2020
ASELAGE STEVE Director
Sold, plan not stated
$39.70K 2,500 at 15.88
1.0%
10 Mar 2020
Clague Laura Chief Financial Officer
Sold, plan not stated
$60.08K 4,000 at 15.02
15.1%
10 Mar 2020
REED ELIZABETH E SVP, GC & Corporate Secretary
Sold, plan not stated
$52.57K 3,500 at 15.02
11.5%
10 Mar 2020
ROTE WILLIAM E. Senior Vice President, R&D
Sold, plan not stated
$48.33K 3,250 at 14.87
11.2%
5 Mar 2020
ASELAGE STEVE Director
Sold, plan not stated
$66.94K 4,359 at 15.36
1.7%
5 Mar 2020
Rosenberg Noah L. Chief Medical Officer
Sold, plan not stated
$27.49K 1,790 at 15.36
6.2%
18 Feb 2020
ROTE WILLIAM E. Senior Vice President, R&D
Sold, plan not stated
$20.69K 1,250 at 16.55
4.6%
14 Feb 2020
ROTE WILLIAM E. Senior Vice President, R&D
Sold, plan not stated
$20.90K 1,250 at 16.72
4.4%
Showing 251–300 of 352. ← Newer Page 6 of 8 Older →